The University of Chicago Header Logo

Search Results (135)

MatchTypeWhy
Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC).Academic Article Why?
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.Academic Article Why?
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.Academic Article Why?
FLT3 inhibitor maintenance after allogeneic stem cell transplantation in FLT3-mutated acute myeloid leukemia (AML) patients.Academic Article Why?
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).Academic Article Why?
The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).Academic Article Why?
Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia.Academic Article Why?
Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia.Academic Article Why?
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.Academic Article Why?
Prognostic significance of the AML1-ETO fusion transcript expression in children and young adults with t(8;21) acute myeloid leukemia.Academic Article Why?
Cheng, Jason X.Person Why?
Identification of pericentric inversion 12, inv(12)(p13.1q11), by fluorescence in situ hybridization in a patient with acute myeloid leukemia (AML-M6).Academic Article Why?
Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study.Academic Article Why?
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.Academic Article Why?
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).Academic Article Why?
Per Page    Page  of 9last Nextnext
Prev
Search Criteria
  • Acute myeloid leukemia
  • AML
Filter by Type
_
Click "Why?" to see why an item matched the search.